Villeurbanne, France

Raphaël Darteil

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 4.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Lille, FR (2007)
  • Villeurbanne, FR (2022)

Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Raphaël Darteil: Innovator in Non-Alcoholic Steatohepatitis Diagnosis

Introduction

Raphaël Darteil is a notable inventor based in Villeurbanne, France. He has made significant contributions to the field of medical diagnostics, particularly in the area of non-alcoholic steatohepatitis (NASH). With a total of 3 patents to his name, Darteil's work is paving the way for advancements in the diagnosis and treatment of liver diseases.

Latest Patents

Darteil's latest patents focus on innovative methods for diagnosing non-alcoholic steatohepatitis. One of his key inventions is a non-invasive diagnostic method for NASH, which allows for the classification of subjects as potential candidates for treatment. Another significant patent involves methods for diagnosing and evaluating NASH, utilizing circulating miRNAs and other blood markers of liver damage. This invention also includes a kit designed for implementing the diagnostic method, along with compounds for treating NASH based on the evaluation results.

Career Highlights

Raphaël Darteil is currently associated with Genfit, a company dedicated to developing innovative solutions for liver diseases. His work at Genfit has been instrumental in advancing the understanding and treatment of NASH. His expertise in the field has led to the development of groundbreaking diagnostic methods that are crucial for patient care.

Collaborations

Darteil collaborates with esteemed colleagues such as Geneviève Cordonnier and John Brozek. Their combined efforts contribute to the ongoing research and development in the field of liver disease diagnostics.

Conclusion

Raphaël Darteil's contributions to the field of non-alcoholic steatohepatitis diagnosis are significant and impactful. His innovative patents and work at Genfit highlight his dedication to improving patient outcomes in liver health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…